« Previous
Next »
Annals of Emergency Medicine
Volume 56, Issue 3
, Pages 278-282
, September 2010
Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series
References
- Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008;372:1174–1183
- Non-allergic angioedema (Role of bradykinin). Allergy. 2007;62:842–856
- Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893–1906
- Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol. 2005;59:233–238
- Plasma bradykinin in angio-oedema. Lancet. 1998;351:1693–1697
- Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (icatibant). J Allergy Clin Immunol. 2007;119:1497–1503
- Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest. 2002;109:1057–1063
- . Biological effects of C1 inhibitor. Drug News Perspect. 2004;17:439–446
- . Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema. Behring Inst Mitt. 1993;93:313–320
- . The pathogenesis of hereditary angioedema. Transfus Apher Sci. 2003;29:195–203
Please see page 279 for the Editor's Capsule Summary of this article.
Supervising editor: Richard C. Dart, MD, PhD
Author contributions: MB, JG, and KS defined the research theme. MB, HB, TKH, and GK designed the methods and study design, analyzed the data, interpreted the results, and wrote the article. TS assisted with associated data collection and their interpretation. All authors have contributed to, seen, and approved the article. MB takes responsibility for the paper as a whole.
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.
Publication date: Available online May 5, 2010.
Reprints not available from the authors.
PII: S0196-0644(10)00279-9
doi: 10.1016/j.annemergmed.2010.03.032
© 2009 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Annals of Emergency Medicine
Volume 56, Issue 3
, Pages 278-282
, September 2010
